Access cutting-edge bronchiolitis obliterans treatment through this clinical trial at a research site in Orlando. Study-provided care at no cost to qualified participants.
Access bronchiolitis obliterans specialists in Orlando at no cost
This study follows strict safety protocols and ethical guidelines
All study-related bronchiolitis obliterans treatment provided free
The goal of this Phase 3 clinical trial is to compare ARINA-1 (a nebulized immunomodulatory agent) plus Standard of Care vs Standard of Care alone. The main question it aims to answer are: * Evaluate the effectiveness of ARINA-1 in preventing bronchiolitis obliterans syndrome (BOS) progression in participants with a bilateral lung transplant * To evaluate the effectiveness of ARINA-1 on improving quality of life decline and preventing or delaying the use of augmented immunosuppression in partic
Sponsor: Renovion, Inc.
Check if you qualify for this bronchiolitis obliterans clinical trial in Orlando, FL
If you're searching for bronchiolitis obliterans treatment options in Orlando, FL, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Orlando research site is actively enrolling participants for this clinical trial. You'll receive care from experienced bronchiolitis obliterans specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.